NKD2 and colorectal carcinoma: The results demonstrated that the high expression levels of DPEP1 (Figure 4A), NKD2 (Figure 4B), CEMIP (Figure 4C), ETV4 (Figure 4D), TESC (Figure 4E), and FUT1 (Figure 4F) were associated with poor outcomes in CRC patients.